| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5616599 | COSETTE | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr, 2016
(8 years ago) | |
|
US5616599 (Pediatric) | COSETTE | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct, 2016
(7 years ago) | |
Azor is owned by Cosette.
Azor contains Amlodipine Besylate; Olmesartan Medoxomil.
Azor has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Azor are:
- US5616599
- US5616599*PED
Azor was authorised for market use on 26 September, 2007.
Azor is available in tablet;oral dosage forms.
Azor can be used as treatment of hypertension.
The generics of Azor are possible to be released after 25 October, 2016.
Drugs and Companies using AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL ingredient
Market Authorisation Date: 26 September, 2007
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL
How can I launch a generic of AZOR before it's drug patent expiration?
More Information on Dosage
AZOR family patents
